Natus Medical, Inc. (BABY) Tops Q2 EPS by 7c; Guides Q3, Q4, FY13 EPS, Revs

August 1, 2013 8:07 AM EDT Send to a Friend
Natus Medical, Inc. (NASDAQ: BABY) reported Q2 EPS of $0.21, $0.07 better than the analyst estimate of $0.14. Revenue for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login